دورية أكاديمية
Comprehensive Assessment and Rational Decision-making: Based on Recent FindingsAbout Safety of Glucagon-like Peptide-1 Receptor Agonists
| العنوان: | Comprehensive Assessment and Rational Decision-making: Based on Recent FindingsAbout Safety of Glucagon-like Peptide-1 Receptor Agonists |
|---|---|
| المؤلفون: | HE Liyun, ZHANG Huabing, LI Yuxiu |
| المصدر: | Xiehe Yixue Zazhi, Vol 13, Iss 6, Pp 948-952 (2022) |
| بيانات النشر: | Editorial Office of Medical Journal of Peking Union Medical College Hospital, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Medicine |
| مصطلحات موضوعية: | glucagon-like peptide-1 receptor agonists, gallbladder diseases, biliary diseases, efficacy of drugs, safety of drugs, Medicine |
| الوصف: | Glucagon-like peptide-1 receptor agonists (GLP-1RAs), as a kind of novel hypoglycemic agent, are widely used in patients with type 2 diabetes. GLP-1RAs are effective in glycemic control with low risk of hypoglycemia, significant weight loss, and cardiovascular benefit and renal protection. The most common adverse effects of GLP-1RAs are mild to moderate gastrointestinal symptoms, which generally resolve over time. The use of GLP-1RAs also increases the risk of gallbladder or biliary diseases, especially when used at higher doses, for longer durations, and for weight loss, but the absolute risk of gallbladder or biliary tract disease is small. Clinicians and patients need to carefully weigh the benefits and risks of GLP-1RAs to make decisions for the rational use of GLP-1RAs. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | Chinese |
| تدمد: | 1674-9081 2022-0391 |
| العلاقة: | https://doaj.org/toc/1674-9081Test |
| DOI: | 10.12290/xhyxzz.2022-0391 |
| الوصول الحر: | https://doaj.org/article/77ba5c899ba7499ca17fac02f24c0974Test |
| رقم الانضمام: | edsdoj.77ba5c899ba7499ca17fac02f24c0974 |
| قاعدة البيانات: | Directory of Open Access Journals |
| تدمد: | 16749081 20220391 |
|---|---|
| DOI: | 10.12290/xhyxzz.2022-0391 |